Insmed (INSM) delivered earnings and revenue surprises of -10.34% and 16.58%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 19小时前
Insmed Reports Second Quarter 2020 Financial Results and Provides Business Update
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the second quarter ended June 30, 2020, and provided a business update.
PR Newswire · 22小时前
Did Hedge Funds Make The Right Call On Insmed Incorporated (INSM)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional invest
Insider Monkey · 3天前
Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/30 16:33
OSI Systems Receives $5 Million Order to Provide Medical Sensors
OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ: OSIS) today announced that its Optoelectronics division has received an order for approximately $5 million from a leading healthcare original equipment manufacturer (OEM) to provide optical sensors fo
Business Wire · 07/28 12:30
OSI Systems Awarded $5 Million Contract to Develop Automated Detection of Biosecurity Risk Items
OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ: OSIS) today announced that its Security division was awarded a contract from the Commonwealth Government of Australia represented through the Department of Agriculture, Water and the Environment ("DAW
Business Wire · 07/27 12:30
Insmed to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its second quarter 2020 financial results on Thursday, August 6, 2020.
PR Newswire · 07/27 12:00
Insmed shares are trading higher after the company's lung infection treatment received a positive opinion from the European Medicines Agency.